These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries). Ormiston J, Webster M, Stewart J, Vrolix M, Whitbourn R, Donohoe D, Knape C, Lansky A, Attizzani GF, Fitzgerald P, Kandzari DE, Wijns W. JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443 [Abstract] [Full Text] [Related]
31. Comparison of Stent Expansion Guided by Optical Coherence Tomography Versus Intravascular Ultrasound: The ILUMIEN II Study (Observational Study of Optical Coherence Tomography [OCT] in Patients Undergoing Fractional Flow Reserve [FFR] and Percutaneous Coronary Intervention). Maehara A, Ben-Yehuda O, Ali Z, Wijns W, Bezerra HG, Shite J, Généreux P, Nichols M, Jenkins P, Witzenbichler B, Mintz GS, Stone GW. JACC Cardiovasc Interv; 2015 Nov; 8(13):1704-14. PubMed ID: 26585621 [Abstract] [Full Text] [Related]
35. In-stent restenosis nine years after initial placement of a drug-eluting stent. Hopkinson DA, Raje V, Jovin IS. Cardiovasc Revasc Med; 2018 Jan; 19(1 Pt A):26-28. PubMed ID: 28546034 [Abstract] [Full Text] [Related]
40. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results. Verheye S, Ormiston JA, Stewart J, Webster M, Sanidas E, Costa R, Costa JR, Chamie D, Abizaid AS, Pinto I, Morrison L, Toyloy S, Bhat V, Yan J, Abizaid A. JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]